Standard Biotools | FLDM - Sales Revenues

Stock Price
0.93
Daily Change
0.04 3.93%
Monthly
-6.17%
Yearly
-10.19%
Q2 Forecast
0.88

Standard Biotools reported $23.8M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Agilent USD 1.8B 63M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Bio-Rad Laboratories USD 693.2M 40.2M Dec/2025
Bruker USD 977.2M 116.7M Dec/2025
Danaher USD 6.84B 790M Dec/2025
Illumina USD 1.16B 80M Dec/2025
Myriad Genetics USD 209.8M 4.1M Dec/2025
Nikon Corporation JPY 170.99B 16.2B Dec/2025
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sony JPY 3.71T 600B Dec/2025
Standard Biotools USD 23.8M 4.24M Dec/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Waters USD 932M 132M Dec/2025